Taub Rebecca
Director at MDGL
- Sold, on record
- $68.2M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Mar 6, 2026
- Form 144 notices
- 12
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MDGLMADRIGAL PHARMACEUTICALS, INC.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice MDGLNoticeJan 9, 2026 2026
Filed to sell 18,650 shares ($10.4M)
Taub Rebecca, Director
10b5-1 plan1.7x usual sizeFiling
- 2 Form 4 sale MDGLRoutineJan 9, 2026 same day
Sold 18,410 shares at $522.40 ($9.6M)
Taub Rebecca, Director
10b5-1 planSold 3.9% of holdings ($248M position)455,589 shares left1.7x usual sizeFollows a Form 144Filing
- 3 Form 4 sale MDGLRoutineJan 9, 2026 same day
Sold 240 shares at $550.33 ($132k)
Taub Rebecca, Director
10b5-1 planSold 0.1% of holdings ($251M position)455,589 shares left0x usual sizeFollows a Form 144Filing
- 4 Form 4 sale MDGLNo planJan 20, 2026 +11 days
Sold 2,238 shares at $490.77 ($1.1M)
Taub Rebecca, Director
No 10b5-1 planSold 0.5% of holdings ($224M position)453,351 shares left0.2x usual sizeFollows a Form 144Filing
- 5 Form 144 notice MDGLNoticeJan 20, 2026 same day
Filed to sell 2,238 shares ($1.1M)
Taub Rebecca, Director
No 10b5-1 plan0.2x usual sizeFiling
- 6 Form 4 sale MDGLNo planJan 26, 2026 +6 days
Sold 647 shares at $492.42 ($319k)
Taub Rebecca, Director
No 10b5-1 planSold 0.1% of holdings ($223M position)452,704 shares left0.2x usual sizeFollows a Form 144Filing
- 7 Form 144 notice MDGLNoticeJan 26, 2026 same day
Filed to sell 647 shares ($311k)
Taub Rebecca, Director
No 10b5-1 plan0.2x usual sizeFiling
- 8 Form 4 sale MDGLNo planMar 6, 2026 +39 days
Sold 491 shares at $431.94 ($212k)
Taub Rebecca, Director
No 10b5-1 planSold 0.1% of holdings ($196M position)452,213 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (25)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 6, 2026 | MDGL | Director | Form 4 sale | 491 | $212k | 0.1% | No plan | SEC |
| Jan 26, 2026 | Jan 26, 2026 | MDGL | Director | Form 144 notice | 647 | $311k | Notice | SEC | |
| Jan 26, 2026 | Jan 26, 2026 | MDGL | Director | Form 4 sale | 647 | $319k | 0.1% | No plan | SEC |
| Jan 20, 2026 | Jan 20, 2026 | MDGL | Director | Form 144 notice | 2,238 | $1.1M | Notice | SEC | |
| Jan 20, 2026 | Jan 20, 2026 | MDGL | Director | Form 4 sale | 2,238 | $1.1M | 0.5% | No plan | SEC |
| Jan 9, 2026 | Jan 13, 2026 | MDGL | Director | Form 4 sale | 240 | $132k | 0.1% | Routine | SEC |
| Jan 9, 2026 | Jan 13, 2026 | MDGL | Director | Form 4 sale | 18,410 | $9.6M | 3.9% | Routine | SEC |
| Jan 9, 2026 | Jan 9, 2026 | MDGL | Director | Form 144 notice | 18,650 | $10.4M | Notice | SEC | |
| Dec 10, 2025 | Dec 12, 2025 | MDGL | Director | Form 4 sale | 18,650 | $10.3M | 3.9% | Unusual | SEC |
| Dec 10, 2025 | Dec 10, 2025 | MDGL | Director | Form 144 notice | 18,650 | $10.3M | Notice | SEC | |
| Aug 12, 2025 | Aug 13, 2025 | MDGL | Director | Form 4 sale | 46,463 | $16.5M | 9.2% | Unusual | SEC |
| Aug 12, 2025 | Aug 12, 2025 | MDGL | Director | Form 144 notice | 43,263 | $15.1M | Notice | SEC | |
| Aug 11, 2025 | Aug 11, 2025 | MDGL | Director | Form 144 notice | 3,200 | $1.1M | Notice | SEC | |
| Jul 18, 2025 | Jul 22, 2025 | MDGL | Director | Form 4 sale | 1,000 | $350k | 0.2% | Routine | SEC |
| Jul 18, 2025 | Jul 18, 2025 | MDGL | Director, Officer | Form 144 notice | 1,000 | $349k | Notice | SEC | |
| Jul 17, 2025 | Jul 18, 2025 | MDGL | Director | Form 4 sale | 29,101 | $10.3M | 5.9% | Unusual | SEC |
| Jul 17, 2025 | Jul 17, 2025 | MDGL | Director, Officer | Form 144 notice | 2,657 | $917k | Notice | SEC | |
| Jul 16, 2025 | Jul 16, 2025 | MDGL | Director, Officer | Form 144 notice | 26,444 | $8.2M | Notice | SEC | |
| Jan 24, 2025 | Jan 27, 2025 | MDGL | Pres., R&D, and CMO | Form 4 sale | 648 | $217k | 0.1% | No plan | SEC |
| Jan 24, 2025 | Jan 24, 2025 | MDGL | Officer, Director | Form 144 notice | 648 | $220k | Notice | SEC | |
| Jan 17, 2025 | Jan 17, 2025 | MDGL | Officer, Director | Form 144 notice | 1,689 | $461k | Notice | SEC | |
| Jan 17, 2025 | Jan 17, 2025 | MDGL | Pres., R&D, and CMO | Form 4 sale | 1,689 | $462k | 0.4% | No plan | SEC |
| Apr 8, 2024 | Apr 10, 2024 | MDGL | Pres., R&D, and CMO | Form 4 sale | 2,676 | $658k | 0.6% | Routine | SEC |
| Apr 5, 2024 | Apr 5, 2024 | MDGL | Pres., R&D, and CMO | Form 4 sale | 73,888 | $18M | 13.9% | Routine | SEC |
| Apr 3, 2024 | Apr 3, 2024 | MDGL | Officer | Form 144 notice | 76,564 | $18.7M | Notice | SEC |